We have shown that SRI 31215 blocks signaling between colon cancer cells and fibroblasts, prevents fibroblast-dependent growth and migration of cancer cells and overcomes fibroblast-induced resistance to inhibitors of EGFR. The gene discussed is EGFR; the disease is malignant colon neoplasm.